Hazra, M. (2022) “A rational pharmacovigilance safety appraisal of topical pefloxacin 0.3% ophthalmological drops in bacterial conjunctivitis, in global multi-centre tertiary care hospitals”, International Journal of Basic & Clinical Pharmacology, 11(4), pp. 302–307. doi: 10.18203/2319-2003.ijbcp20221595.